Enlivex – a Hadasit start-up company (under HBL) which develops a preventive immune-modulatory treatment invented by Prof. Dror Mevorach and his laboratory at Hadassah Medical Center - has successfully completed the first Phase I/IIa clinical trial for testing the safety and preliminary assessment of the effectiveness of ApoCell in the prevention and treatment of graft-versus-host disease (GVHD), a devastating and potentially life-threatening complication that occurs in 50-70% of patients receiving bone-marrow transplantation.
As I write this, negotiations for a ceasefire are taking place, while rockets and missiles continue to hit Israeli cities and towns--some a considerable distance from the Gaza Strip. This is a very difficult time, a very challenging time, yet there is a hope for a better future.
The Hadassah Director of External Relations updates the role of the Hadassah Hospitals as the conflict continues in Gaza
Through his long-time collaboration with the St. John Eye Hospital in East Jerusalem, Prof. Saul Merin, Hadassah University Medical Center ophthalmologist, was a role model for building bridges between Israelis and Palestinians through medicine.
The Hadassah Medical Center’s Community Health Promotion Program for women aged 60 and above in the Gilo neighborhood of Jerusalem celebrated the graduation of 42 volunteer leaders in September.
Since the opening of the renovated and expanded Pediatrics Wing B at Hadassah Hospital-Mount Scopus in February 2011, more than 3,000 children, mirroring the diversity of Israel’s population, have been hospitalized in the new state-of-the-art space.
When the Hadassah University Medical Center’s physicians suggest a solution to a medical problem which can lead to the development of a new medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its feasibility and supports the promotion of those viable ideas with innovation potential.
With the publication of Start-Up Nation, the phrase has become synonymous with Israeli imagination and invention. Yet long before this informative book was published, long before computers became commonplace, even long before Israel was founded, the Hadassah Medical Organization fashioned the template for healthcare start-ups.
While over 95 percent of children are cured of retinoblastoma, a malignant tumor of the eye, the Hadassah University Medical Center’s specialists are focusing on the quality of life (QOL) issues that plague these young patients.
There are many ways to measure excellence. Some people judge by reputation or demand, and they are important criteria, but for us at HMO the yardstick for excellence is the level of performance--in the past, in the present and the potential for the future.